Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis J Immunother Cancer
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials Haematologica
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma Front Immunol
MYC activation impairs cell-intrinsic IFNy signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer Cell Rep Med
An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations JOVE-J VIS EXP
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? Int J Mol Sci
Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018) CANCER MED-US
Iron overload refractory to phlebotomy in a patient with type 1 hereditary hemochromatosis MED CLIN-BARCELONA
